FDA Inspection 1007458 — Guilherme Rollin
The FDA completed an inspection of Guilherme Rollin on Mar 17, 2017 in Rio Grande do Sul 90035-001. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rio Grande do Sul 90035-001 (Brazil)
Additional Details
Clinical Investigator (CI)